Cite Filings / DYN / 0001193125-24-002687
Feed Companies Filings Check
Sign in
S-3MEF

Filing

Dyne Therapeutics, Inc. · Filed 2024-01-04 · Acc 0001193125-24-002687

Documents 1

  • S-3MEF , d100228ds3mef.htm

Around this filing

  • 2024-01-04 S-3MEF S-3MEF
  • 2024-01-04 4 CEO & President sold 269,719 shares at an average $18.66 ($5,032,915)
  • 2024-01-04 4 Chief Scientific Officer sold 87,779 shares at an average $18.57 ($1,629,985)
  • 2024-01-04 4 Chief Business Officer sold 31,900 shares at an average $16.59 ($529,194)
  • 2024-01-04 4 SVP, Head of Finance & Admin. sold 13,000 shares at $18.81 ($244,530)
  • 2024-01-04 144 Sale of Securities
  • 2024-01-04 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d100228ds3mef.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…